Approval · Notice of Compliance 14240 · 2013
CYTOSAR: Notice of Compliance 14240
Issued March 21, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14240
- Date
- March 21, 2013
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form; solution for injection
- Therapeutic class
- Antileukemic agent
Products in this notice
Medicinal ingredients
- CYTARABINE 20 MG per ML
- CYTARABINE 100 MG per ML